Home > Offer to Sell > Pharmaceuticals and Biochemicals > Biochemicals and biotech products > Dapagliflozin

Dapagliflozin

Inquiry
  Post Date: Nov 21,2014
  Expiry Date: Nov 21,2015
  Detailed Description: Cas No. :461432-26-8 HP4022 Dapagliflozin CAS 461432-26-8
Dapagliflozin CAS 461432-26-8 Brand: Hyper
MW:408.873 MSDS: Avaiable
MF :C21H25ClO6 Dapagliflozin
Category:Diabetes drug Min order: 10grams
Quality standard : Purity 99% min Place of Origin:China
Introduction Dapagliflozin is a drug used to treat type 2 diabetes. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca. Although dapagliflozin's method of action would operate on both types of diabetes and other conditions resulting in hyperglycemia, the current clinical trials specifically exclude participants with type 1 diabetes.
Applications Dapagliflozin A sodium-glucose transporter 2 inhibitor ,Pharmaceutical raw materials

  CAS Registry Number:

461432-26-8
  Synonyms: ;Dapagliflozin;BMS-512148;(1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol;d-glucitol, 1,5-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1s)-;Dapagliflozin free base;
  Molecular Formula: C21H25ClO6
  Molecular Weight: 408.8726
  Molecular Structure: 461432-26-8 (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

  Company: Hongkong Geehon International Limited.     [ China ]          
  Contact: Ms.Linda Ou
  Tel: 00852-2793 5511
  Fax: 00852-3590 2333
  Email: hkgeehon@gmail.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.